Le Lézard
Classified in: Health
Subjects: PDT, MAT

Labor Day Sale Event at FAB CBD


Looking for the best CBD deals this Labor Day? Look no further.

MILWAUKEE, Sept. 1, 2022 /PRNewswire/ -- Labor Day - it's around the time when kids go back to school, and adults...keep working. Offering some relief to the folks out there making a living, FABCBD marks down prices by 30% from September 1st through September 6th.

FAB CBD starts their big Labor Day sale today, offering 30% off all products for a limited time.

The 30% discount is easy for anyone to grab. Just enter the coupon code LABORDAY30 at checkout to receive FAB's top-shelf products for about a third off the regular price. 

Since 2017, the FAB team has been on a mission to boost people's health through the careful and meticulous creation of high-quality, full spectrum, broad spectrum, and CBD isolate products. To that end, FAB continually strives to find ways for a new generation of people to live a preventative wellness lifestyle through science, innovation, and premium supplementation.

FABCBD continues to grow as a company and as a brand by pushing the envelope in its newest offerings. And though it has only been on the market for a short while, the brand's new complete cannabinoid soft gels are beating out competitors' capsules because they are vegan, easier to swallow, totally tasteless, and they have equal parts CBD, CBN, CBG, and CBC. The company's powerful CBD+CBG oil was launched in the past year, and is already a huge hit with countless customers.

FAB remains a top brand in the CBD industry because the team dedicates their time, effort, and knowledge to product creation from seed to sale. Moreover, they also work nonstop to bring new and innovative products to every one of its customers. So, not only is FAB improving upon its already amazing pre-existing products, the brand is also crafting new, clean, organic, potent products to enhance the lives and lifestyles of its customers. With an eye to the future, FABCBD plans to unveil a completely fresh product? D9 gummies? before the end of 2022.

During FAB's Labor Day sale, customers can use the coupon code LABORDAY30 to receive 30% off of the brand's line of CBD products which include its full-spectrum CBD oils in an array of strengths and flavors, CBD gummies, topical CBD cream and body salve, CBD dog treats, CBD+CBG oil, and complete cannabinoid soft gels.

Coupon Code: LABORDAY30

Shop The Sale Through September 6th: https://www.fabcbd.com/pages/labor-day-sale

SOURCE FAB CBD


These press releases may also interest you

at 05:09
Sectra publishes Annual Report and Sustainability Report for 2023/2024
Medical imaging IT and cybersecurity company Sectra (STO: SECT B) is publishing its Annual Report and Sustainability Report for the 2023/2024 fiscal year today. This report also includes the Corporate Governance Report for the same period. The...

at 03:20
Launch of Phase 3 clinical trial with Nefecon in Japan
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
India-Based Dhiti Omics is Now Live on SOPHiA DDMtm
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech Provides Update on Phase II/III SKYSCRAPER-06 Study in Metastatic Non-Squamous Non-Small Cell Lung Cancer
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI: Appointment of Adviser
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

More news about Health...


News published on and distributed by: